Mahoney assumes CEO post at Boston Scientific

Michael Mahoney has assumed the role of president and CEO of Natick, Mass.-based medical device company Boston Scientific Corp., effective Nov. 1. He succeeds interim CEO Hank Kucheman.

Mahoney, 47, was named president and CEO of Boston Scientific in Sept. 2011, following the May announcement that Raymond Elliott would step down after two years as CEO. Mahoney assumed the role of president in October 2011, but because of non-compete obligations with his former employer, New Brunswick, N.J.-based Johnson & Johnson, it was more than a year before he was able to formally transition into the CEO post.

Prior to joining Boston Scientific, Mahoney was worldwide chairman of Johnson & Johnson's medical devices and diagnostics group.

Mahoney was also named to the Boston Scientific's board of directors, taking a seat formerly occupied by Kucheman. Kucheman will stay on as an adviser and member of senior management until the end of the year, when he'll become a consultant to the company, according to a news release.